The Lazio Regional Administrative Court confirmed the suspension of the Decree adopted by the Ministry of Health on 5 August 2023 - presented by Imprenditori Canapa Italia - which included cannabidiol (CBD) among the medicines containing narcotic substances and postponed the decision to the hearing on the merits on 16 January 2024. "In justifying its decision," said Marco Perduca, the president of the Luca Cos "the TAR confirmed the problems of 'investigation' that we had reported this summer, a diplomatic formula to denounce the absence or superficiality of the scientific arguments brought to justify the decision." "In addition," says the ex-senator, "the TAR clearly writes that there do not appear to be imminent risks for the protection of public health and that, also for this reason, the conditions for the suspension of the decree exist." "Finally," Perduca concludes, "the TAR recalled AIFA's opinion of 19 March 2021, which was based on the WHO's recommendation on the exclusion of pure CBD preparations from the list of addictive substances to which Minister Speranza first, and then Schillaci, had responded by opposing a recommendation of a UN body that talks about health and science with a decision taken by a political body, the United Nations Commission on Drugs. It will be imperative to insist on a thorough examination of the scientific evidence that supported the World Health Organization's recommendation and has since bolstered the medical-scientific consensus regarding CBD, prior to the hearing on the merits. Minister Schillaci should abandon the umpteenth prohibitionist battle in favor of making such items available to people in need."